EE119 Cost Effectiveness of Asciminib for the Post 2 Tyrosine Kinase Inhibitor Treatment of Chronic Phase Chronic Myeloid Leukaemia in Türkiye. - Tatar, M; Kaplan, B; Arbay, D; Akdemir, AC (Value in Health, 2024)